Basic Information
| RNALocate ID: | RLID:11001568 |
| RNA Symbol: | hsa-miR-224-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-224-5p |
| RNA ID: | miRBase:MIMAT0000281 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23382797 |
| Tissue/Cell Line: | Brain tissue |
| Method: | Microarray |
| Description: | We performed miRNA expression analysis using a FlexMAP3D instrument by (Luminex Corporation, Austin, TX) and a manufacturer's assay for 312 miRNA (Table S1). Data are collected from Table S1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001681 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001682 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001683 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001684 | Nucleolus | Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11001569 | Exosome | Plasma | 23663360 |
| RLID:11001570 | Exosome | Plasma|Serum | 24683445 |
| RLID-D:11000066 | Exosome | Breast milk|Endothelial cells|Tongue tissue | |
| RLID-D:11000340 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-224-5p | Oral squamous cell carcinoma | MNDR-E-MI-31523 |
| MNDR | hsa-miR-224-5p | Medulloblastoma | MNDR-E-MI-31524 |
| MNDR | hsa-miR-224-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-31525 |
| MNDR | hsa-miR-224-5p | Lymphoma | MNDR-E-MI-31526 |
| MNDR | hsa-miR-224-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-31527 |
| MNDR | hsa-miR-224-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-31528 |
| MNDR | hsa-miR-224-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-31529 |
| MNDR | hsa-miR-224-5p | Breast cancer luminal | MNDR-E-MI-31530 |
| MNDR | hsa-miR-224-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-31531 |
| MNDR | hsa-miR-224-5p | Colorectal carcinoma | MNDR-E-MI-31532 |
| MNDR | hsa-miR-224-5p | Prostate cancer | MNDR-E-MI-31533 |
| MNDR | hsa-miR-224-5p | Gastric cancer | MNDR-E-MI-31534 |
| MNDR | hsa-miR-224-5p | Alzheimer disease | MNDR-E-MI-31535 |
| MNDR | hsa-miR-224-5p | Intracranial aneurysm | MNDR-E-MI-31536 |
| MNDR | hsa-miR-224-5p | Esophageal carcinoma | MNDR-E-MI-31537 |
| MNDR | hsa-miR-224-5p | Dysautonomia familial | MNDR-E-MI-31538 |
| MNDR | hsa-miR-224-5p | Head and neck cancer | MNDR-E-MI-31539 |
| MNDR | hsa-miR-224-5p | Lewy body dementia | MNDR-E-MI-31540 |
| MNDR | hsa-miR-224-5p | Huntington disease | MNDR-E-MI-31541 |
| MNDR | hsa-miR-224-5p | Chorea | MNDR-E-MI-31542 |
| MNDR | hsa-miR-224-5p | Cardiovascular disease | MNDR-E-MI-31543 |
| MNDR | hsa-miR-224-5p | Lung cancer | MNDR-E-MI-31544 |
| MNDR | hsa-miR-224-5p | Down syndrome | MNDR-E-MI-31545 |
| MNDR | hsa-miR-224-5p | Parkinson disease | MNDR-E-MI-31546 |
| MNDR | hsa-miR-224-5p | Breast cancer | MNDR-E-MI-31547 |
| MNDR | hsa-miR-224-5p | Pancreatic cancer | MNDR-E-MI-31548 |
| MNDR | hsa-miR-224-5p | Hepatitis C | MNDR-E-MI-31549 |
| MNDR | hsa-miR-224-5p | Melanoma | MNDR-E-MI-31550 |
| MNDR | hsa-miR-224-5p | Rectum adenocarcinoma | MNDR-E-MI-31551 |
| MNDR | hsa-miR-224-5p | Giant cell tumor | MNDR-E-MI-31552 |
| MNDR | hsa-miR-224-5p | Nephroblastoma | MNDR-E-MI-31553 |
| MNDR | hsa-miR-224-5p | Colon cancer | MNDR-E-MI-31554 |
| MNDR | hsa-miR-224-5p | Colon adenocarcinoma | MNDR-E-MI-31555 |
| MNDR | hsa-miR-224-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-31556 |
| MNDR | hsa-miR-224-5p | Familial ovarian cancer | MNDR-E-MI-31557 |
| MNDR | hsa-mir-224-5p | Ovarian cancer | MNDR-E-MI-31558 |
| MNDR | hsa-miR-224-5p | Prostate adenocarcinoma | MNDR-E-MI-31559 |
| MNDR | hsa-miR-224-5p | Kidney cancer | MNDR-E-MI-31560 |
| MNDR | hsa-miR-224-5p | Carcinoma ductal breast | MNDR-E-MI-31561 |
| MNDR | hsa-miR-224-5p | Glioblastoma | MNDR-E-MI-31562 |
| MNDR | hsa-miR-224-5p | Astrocytoma | MNDR-E-MI-31563 |
| MNDR | hsa-miR-224-5p | Glioma | MNDR-E-MI-31564 |
| MNDR | hsa-miR-224-5p | Osteosarcoma | MNDR-E-MI-31565 |
| MNDR | hsa-miR-224-5p | Liposarcoma | MNDR-E-MI-31566 |
| MNDR | hsa-miR-224-5p | Infarction middle cerebral artery | MNDR-E-MI-31567 |
| MNDR | hsa-miR-224-5p | Meningioma | MNDR-E-MI-31568 |
| MNDR | hsa-miR-224-5p | Cervical adenocarcinoma | MNDR-E-MI-31569 |
| MNDR | hsa-miR-224-5p | Cervical squamous cell carcinoma | MNDR-E-MI-31570 |
| MNDR | hsa-miR-224-5p | Lung squamous cell carcinoma | MNDR-E-MI-31571 |
| MNDR | hsa-miR-224-5p | Carcinoma lung non-small-cell | MNDR-E-MI-31572 |
| MNDR | hsa-miR-224-5p | Lung adenocarcinoma | MNDR-E-MI-31573 |
| MNDR | hsa-miR-224-5p | Thyroid carcinoma | MNDR-E-MI-31574 |
| MNDR | hsa-miR-224-5p | Ovarian carcinoma | MNDR-E-MI-31575 |
| MNDR | hsa-miR-224-5p | Bladder urothelial carcinoma | MNDR-E-MI-31576 |
| MNDR | hsa-miR-224-5p | Pancreatic adenocarcinoma | MNDR-E-MI-31577 |
| MNDR | hsa-miR-224-5p | Brain stem cancer | MNDR-E-MI-31578 |
| MNDR | hsa-miR-224-5p | Carcinoma renal cell | MNDR-E-MI-31579 |
| MNDR | hsa-miR-224-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-31580 |
| MNDR | hsa-miR-224-5p | Clear cell renal cell carcinoma | MNDR-E-MI-31581 |
| MNDR | hsa-miR-224-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-31582 |
| MNDR | hsa-miR-224-5p | Cholangiocarcinoma | MNDR-E-MI-31583 |
| MNDR | hsa-miR-224-5p | Esophageal cancer | MNDR-E-MI-31584 |
| MNDR | hsa-miR-224-5p | Oncocytoma | MNDR-E-MI-31585 |
| MNDR | hsa-miR-224-5p | Synovial sarcoma | MNDR-E-MI-31586 |
| MNDR | hsa-miR-224-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-31587 |
| MNDR | hsa-miR-224-5p | Uveal melanoma | MNDR-E-MI-31588 |
| MNDR | hsa-miR-224-5p | Breast invasive carcinoma | MNDR-E-MI-31589 |
| MNDR | hsa-miR-224-5p | Hepatocellular carcinoma | MNDR-E-MI-31590 |
| MNDR | hsa-mir-224-5p | Hepatocellular carcinoma | MNDR-E-MI-31591 |
| MNDR | hsa-miR-224-5p | Familiar ovarian carcinoma | MNDR-E-MI-31592 |
| MNDR | hsa-miR-224-5p | B-cell lymphoma | MNDR-E-MI-31593 |
| MNDR | hsa-miR-224-5p | Rheumatoid arthritis | MNDR-E-MI-31594 |
| MNDR | hsa-miR-224-5p | Retinoblastoma | MNDR-E-MI-31595 |
| MNDR | hsa-miR-224-5p | Hodgkin lymphoma | MNDR-E-MI-31596 |
| MNDR | hsa-miR-224-5p | Skin cutaneous melanoma | MNDR-E-MI-31597 |
| MNDR | hsa-miR-224-5p | Skin melanoma | MNDR-E-MI-31598 |
| MNDR | hsa-miR-224-5p | Acute myelogenous leukemia | MNDR-E-MI-31599 |
| MNDR | hsa-miR-224-5p | Colorectal cancer | MNDR-E-MI-31600 |
| MNDR | hsa-miR-224-5p | Nasopharynx carcinoma | MNDR-E-MI-31601 |
| MNDR | hsa-miR-224-5p | Acute lymphocytic leukemia | MNDR-E-MI-31602 |
| MNDR | hsa-miR-224-5p | Uterine cervical neoplasms | MNDR-E-MI-31603 |
| MNDR | hsa-miR-224-5p | Nasopharyngeal cancer | MNDR-E-MI-31604 |
| MNDR | hsa-miR-224-5p | Prostatic neoplasms | MNDR-E-MI-31605 |
| MNDR | hsa-miR-224-5p | Duke A | MNDR-E-MI-31606 |
| MNDR | hsa-miR-224-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-31607 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AKT1 | Homo sapiens | RR00067002 |
TOP